Address Information


E-mail CVBT

Investor Inquiry

Scientific Inquiry
General and Press Inquiries

Clinical Trial Inquiries



   
General Inquiry  
 

Thank you for your interest in CardioVascular BioTherapeutics, Inc. We'll respond to your inquiry within three business days.

First Name 
Last Name 
Title 
Company/Organization 
Address 1 
Address 2 
City 
State/Province 
Postal Code 
Country 
Phone 
FAX 
Email Address 

Comments/Questions:

 


This information is private and confidential and will be for corporate use only. It will not be shared or disseminated. At any time if you wish to be removed from this database, simply contact the CVBT Corporate office or email us and you will be removed promptly.

 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

11/25/2008
CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease


11/13/2008
CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate


9/9/2008
CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial


7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates